Electrophysiological mechanism of enhanced susceptibility of hypertrophied heart to acquired Torsade de Pointes arrhythmias - Tridimensional mapping of activation and recovery patterns

被引:68
作者
Kozhevnikov, DO
Yamamoto, K
Robotis, D
Restivo, M
El-Sherif, N
机构
[1] SUNY Hlth Sci Ctr, Div Cardiol, Dept Med, Brooklyn, NY 11203 USA
[2] NY Harbor Hlth Care Syst, Brooklyn, NY USA
关键词
hypertrophy; torsade de pointes; long-QT syndrome; antiarrhythmia agents;
D O I
10.1161/hc0902.104711
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Cardiac hypertrophy is associated with increased incidence of sudden death and susceptibility to proarrhythmic effects of antiarrhythmic agents. However, the in vivo electrophysiologic mechanism of the arrhythmias has not been investigated in detail. Methods and Results-Dose-dependent susceptibility to Torsade de Pointes (TdP) by class III drug dofetilide, 3, 10, and 30 mug/kg, was compared in 6 control dogs (C) and in 5 dogs 6 to 8 weeks after induction of complete atrioventricular block (AVB) that resulted in ventricular hypertrophy (H). Tridimensional ventricular activation and repolarization (R) patterns were simultaneously analyzed from unipolar extracellular electrograms, and local R was measured from activation recovery intervals. Both R and transmural dispersion of R (TDR) were significantly greater in dogs with H compared,with C. Dofetilide resulted in cycle length-dependent and c dose-dependent prolongation of R. which was more marked in left ventricular endocardium/midmyocardium compared with epicardium. resulting in significant increase of TDR. These changes were more accentuated in dogs with H compared with C. All 5 dogs with H developed UP at a dose of 3 to 10 mug/kg, whereas only 1 of 6 C dogs developed TO at 30 mug/kg. UP was initiated by subendocardial focal activity that infringed on TDR, resulting in functional conduction block and reentrant excitation. Conclusions-Enhanced susceptibility of hypertrophied heart to class III drugs is attributable to baseline increased TDR and greater dose-related accentuation of TDR compared with nonhypertrophied heart. This provides the electrophysiologic substrate for drug-induced TdP.
引用
收藏
页码:1128 / 1134
页数:7
相关论文
共 18 条
[1]  
Anyukhovsky EP, 1997, CIRCULATION, V96, P4019
[2]   Regional differences in electrophysiological properties of epicardium, midmyocardium, and endocardium - In vitro and in vivo correlations [J].
Anyukhovsky, EP ;
Sosunov, EA ;
Rosen, MR .
CIRCULATION, 1996, 94 (08) :1981-1988
[3]   Rate- and site-dependent effects of propafenone, dofetilide and the new IKs-blocking agent chromanol 293b on individual muscle layers of the intact canine heart [J].
Bauer, A ;
Becker, R ;
Freigang, KD ;
Senges, JC ;
Voss, F ;
Hansen, A ;
Müller, M ;
Lang, HJ ;
Gerlach, U ;
Busch, A ;
Kraft, P ;
Kübler, W ;
Schöls, W .
CIRCULATION, 1999, 100 (21) :2184-2190
[4]   COMPARISON OF QT DISPERSION IN HYPERTROPHIC CARDIOMYOPATHY BETWEEN PATIENTS WITH AND WITHOUT VENTRICULAR ARRHYTHMIAS AND SUDDEN-DEATH [J].
BUJA, G ;
MIORELLI, M ;
TURRINI, P ;
MELACINI, P ;
NAVA, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (12) :973-976
[5]   DOSE-DEPENDENT MODULATION OF THE CARDIAC SODIUM-CHANNEL BY SEA-ANEMONE TOXIN-ATXII [J].
ELSHERIF, N ;
FOZZARD, HA ;
HANCK, DA .
CIRCULATION RESEARCH, 1992, 70 (02) :285-301
[6]   The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome - Tridimensional mapping of activation and recovery patterns [J].
ElSherif, N ;
Caref, EB ;
Yin, H ;
Restivo, M .
CIRCULATION RESEARCH, 1996, 79 (03) :474-492
[7]   Dispersion of ventricular repolarization in left ventricular hypertrophy: Influence of afterload and dofetilide [J].
Gillis, AM ;
Mathison, HJ ;
Kulisz, E ;
Lester, WM .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1998, 9 (09) :988-997
[8]   PROGNOSTIC IMPLICATIONS OF ECHOCARDIOGRAPHICALLY DETERMINED LEFT-VENTRICULAR MASS IN THE FRAMINGHAM-HEART-STUDY [J].
LEVY, D ;
GARRISON, RJ ;
SAVAGE, DD ;
KANNEL, WB ;
CASTELLI, WP .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (22) :1561-1566
[9]   Pause-dependent polymorphic ventricular tachycardia during long-term treatment with dofetilide - A placebo-controlled, implantable cardioverter-defibrillator-based evaluation [J].
Mazur, A ;
Anderson, ME ;
Bonney, S ;
Roden, DM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (04) :1100-1105
[10]  
Mounsey JP, 2000, CIRCULATION, V102, P2665